Skip to main content

Table 3 Cosmetic outcomes according to Harvard Scale by (A) physician and (B) patients

From: IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study

Time point

Cosmetic rating

IOERT (125)

EBRT (110)

p value*

(A) Physician’s evaluation

 Before RT

Excellent/good

96 (77%)

66 (60%)

0.01

Fair/Poor

29 (23%)

44 (40%)

 End RT

Excellent/good

91 (73%)

62 (56%)

0.006

Fair/poor

34 (27%)

48 (44%)

 1 month after RT

Excellent/good

99 (79%)

74 (67%)

0.03

Fair/poor

26 (21%)

36 (33%)

 6 months after RT

Excellent/good

103 (82%)

78 (71%)

0.05

Fair/poor

22 (18%)

32 (29%)

 12 months after RT

Excellent/good

104 (83%)

80 (73%)

0.08

Fair/poor

21 (17%)

30 (27%)

(B) Patients’ evaluation

 Before RT

Excellent/good

81 (65%)

52 (47%)

0.006

Fair/poor

44 (35%)

58 (53%)

 End RT

Excellent/good

78 (62%)

43 (39%)

0.0004

Fair/poor

47 (38%)

67 (61%)

 1 month after RT

Excellent/good

91 (73%)

59 (54%)

0.001

Fair/poor

34 (27%)

51 (46%)

 6 months after RT

Excellent/good

103 (82%)

73 (66%)

0.005

Fair/poor

22 (18%)

37 (34%)

 12 months after RT

Excellent/good

105 (84%)

80 (73%)

0.04

Fair/poor

20 (16%)

30 (27%)

  1. *Chi-square test